Gear, Growth, and Gains Ep. 017 Release
Janoshik Laughs Off Bribery, Says SLU-PP-332 is NOT Meant for Vials, and Talks About a Sharp Influx in Counterfeit Steroids… Masteron, However, Has Been Mostly Real!
Listen
Summary
Outline & Timestamps
Podcast Introduction and Disclaimers (00:00:30) Host introduces the show, gives disclaimers, and promotes Meso-Rx and related platforms.
Type-IIx Insider Program Launch (00:02:06) Details about the new premium content program, symposiums, ebooks, and a limited-time discount.
Guest Introduction: Peter Magic / Janosik (00:02:55) Host introduces Peter Magic (Janosik), his background, and his company’s focus on testing peptides and steroids.
Origin of the Janosik Name (00:03:16) Peter explains the significance of the Janosik name and its Slovakian roots.
Janosik as a Folk Hero (00:03:46) Discussion about Janosik as a real-life Robin Hood figure in Slovak folklore.
Starting the Testing Business (00:04:17) Peter describes how and why he started his testing business around 2012-2013.
Transition to Building a Team (00:05:10) Peter discusses moving from solo work to hiring staff and scaling the company over the last five years.
Lab Equipment and Analytical Methods (00:06:29) Overview of the lab’s equipment, including HPLC, LCMS, and GCMS, and their uses in compound identification.
Novel and Unlisted Compounds (00:09:07) Peter talks about encountering novel compounds not found in standard databases, including experimental cannabinoids.
Personal Accomplishments (00:10:11) Peter shares personal achievements, including his children and powerlifting milestones.
Most Egregious Fake or Underdosed Products (00:12:13) Discussion of recent trends in fake or underdosed products, including steroids replaced with other substances.
Current State of the Anabolic Steroid Market (00:14:45) Peter describes the decline in quality and availability of anabolic steroids and raw materials, especially from China.
Peptide Market Trends and Sloopy 332 (00:17:48) Discussion about the peptide market, Sloopy 332, and issues with its formulation and solubility.
Testing NAD+ vs. Peptides (00:20:45) Comparison of testing methods for NAD+ and peptides, and challenges in purity assessment.
Challenges Testing hCG and HMG (00:23:26) Explains difficulties in testing hCG and HMG due to molecular variability and manufacturing differences.
IGF Peptide Authenticity (00:26:32) Peter discusses the rarity of authentic IGF-1 samples and issues with degradation and market quality.
Price vs. Quality in IGF Peptides (00:29:15) No correlation found between price and quality in IGF peptides based on testing data.
Endotoxins in Samples (00:29:53) Overview of endotoxin testing, its relevance, and the impact of manufacturing methods on contamination.
Manufacturing Methods and Endotoxin Risk (00:33:12) Differences between E. coli and mammalian cell line production, and their effects on endotoxin contamination.
Injection Safety and Endotoxin Risks (00:34:33) Discussion on the relative safety of subcutaneous injections and minor risks associated with endotoxins.
Peptide Stability and Degradation Experiments (00:36:16) Peter shares findings from informal experiments on peptide stability, agitation, and thermal stress.
Bribery and Maintaining Independence (00:39:24) Peter recounts experiences with bribery attempts and how company growth ensures independence and integrity.
Other Testing Companies and Industry Ethics (00:40:55) Peter critiques other testing labs, highlighting issues with legitimacy, transparency, and accountability.
Importance of Team and Employee Recognition (00:44:58) Peter emphasizes the contributions of his team and wishes for more recognition of their work.
Podcast Wrap-Up and Final Promotions (00:46:00) Host thanks Peter, wraps up the episode, and promotes related forums and lab work services.